Fluorescence‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid

Protoporphyrin IX‐fluorescence measurement is a powerful in situ approach for cancer detection after oral/topical administration of 5‐aminolevulinic acid. However, this approach has not been clinically established for breast cancer, probably due to insufficient delivery of 5‐aminolevulinic acid to t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Morita, Midori, Tanaka, Hideo, Kumamoto, Yasuaki, Nakamura, Akihiro, Harada, Yoshinori, Ogata, Takehiro, Sakaguchi, Koichi, Taguchi, Tetsuya, Takamatsu, Tetsuro
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746108/
https://ncbi.nlm.nih.gov/pubmed/31385432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2466
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky